Lehigh University

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Lehigh University sits in the top decile of US sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count).

12 total trials 3 currently recruiting 7 completed top decile by trial count

Lehigh University: 12 sponsored US clinical trials, 3 recruiting.

Lehigh University sponsors 12 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 7 completed. The most-studied condition in this pipeline is Smoking Cessation, with 2 trials.

Top-decile sponsor footprint

Lehigh University ranks in the top decile of sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

What is open in the Lehigh University pipeline

3 recruiting of 12 indexed (25% open); 7 completed (58%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Smoking Cessation (2 trials), 6 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Lehigh University: open-pipeline peers nationwide

Peers matched on 12 registered trials and 25% open enrollment, not the therapeutic-area sidebar.

Lehigh University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 2468101214 0%10%20%30% Total trials Recruiting share Lehigh UniversityAlachua Government ServicesAllergy TherapeuticsAmpio Pharmaceuticals.AngiodynamicsAB ScienceAbbott Point of CareAbdul Latif Jameel Poverty Action LabAccutar Biotechnology
Lehigh University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Lehigh University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 12 trials (± recruiting share)

Sponsors near 25% open enrollment (± trial volume)

What to do with this Lehigh University page

12 registered trials is a research-attention snapshot, not an endorsement of Lehigh University or any single study.

  • 3 of Lehigh University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Smoking Cessation is the condition Lehigh University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Smoking Cessation trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Lehigh University pipeline card: 12 registered trials from official public datasets.Report a data error.